# FDA Inspection 1026899 - Octapharma Plasma Inc - September 15, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/75b2e07a-e3b9-4afc-9628-c0d403438c30
Source feed: FDA_Inspections

> FDA Inspection 1026899 for Octapharma Plasma Inc on September 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026899
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2017-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1063662 - 2018-07-13](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/bcf328d0-ee00-498f-91f7-800811f8d342)
- [FDA Inspection 916423 - 2015-03-04](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/c3f579df-40e5-4b58-903c-9b76632a8810)

Company: https://www.globalkeysolutions.net/companies/octapharma-plasma-inc/fdd1fd3f-18f9-4629-b2cf-a142731977ea

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d